MSP Recovery (NASDAQ:MSPR – Get Free Report) and Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.
Volatility and Risk
MSP Recovery has a beta of -2.38, meaning that its share price is 338% less volatile than the S&P 500. Comparatively, Strata Skin Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500.
Earnings and Valuation
This table compares MSP Recovery and Strata Skin Sciences”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| MSP Recovery | $9.81 million | 0.03 | -$360.50 million | ($572.83) | 0.00 |
| Strata Skin Sciences | $30.98 million | 0.02 | -$10.09 million | ($1.41) | -0.09 |
Strata Skin Sciences has higher revenue and earnings than MSP Recovery. Strata Skin Sciences is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
3.8% of MSP Recovery shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 50.5% of MSP Recovery shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares MSP Recovery and Strata Skin Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| MSP Recovery | -7,328.48% | -326.80% | -81.27% |
| Strata Skin Sciences | -35.64% | -476.73% | -33.49% |
Analyst Ratings
This is a summary of recent recommendations for MSP Recovery and Strata Skin Sciences, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
| Strata Skin Sciences | 1 | 0 | 0 | 0 | 1.00 |
Summary
Strata Skin Sciences beats MSP Recovery on 7 of the 11 factors compared between the two stocks.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
About Strata Skin Sciences
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Receive News & Ratings for MSP Recovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSP Recovery and related companies with MarketBeat.com's FREE daily email newsletter.
